<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id>
      <journal-id journal-id-type="publisher-id">MEDI</journal-id>
      <journal-title-group>
        <journal-title>Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0025-7974</issn>
      <issn pub-type="epub">1536-5964</issn>
      <publisher>
        <publisher-name>Wolters Kluwer Health</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27057865</article-id>
      <article-id pub-id-type="pmc">4998781</article-id>
      <article-id pub-id-type="doi">10.1097/MD.0000000000003246</article-id>
      <article-id pub-id-type="art-access-id">03246</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>5700</subject>
        </subj-group>
        <subj-group>
          <subject>Research Article</subject>
          <subject>Clinical Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Carcinosarcoma of the Lesser Omentum</article-title>
        <subtitle>A Unique Case Report and Literature Review</subtitle>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Bei</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ren</surname>
            <given-names>Kui-Wu</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Yun-Chuan</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wan</surname>
            <given-names>Da-Long</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Xue-Jie</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhai</surname>
            <given-names>Zheng-Long</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Le-Le</given-names>
          </name>
          <degrees>MD</degrees>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zheng</surname>
            <given-names>Shu-Sen</given-names>
          </name>
          <degrees>MD, PhD</degrees>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Ling.</surname>
            <given-names>Shizhang</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff>From the Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, Key Laboratory of Organ Transplantation, Division of Hepatobiliary and Pancreatic Surgery (BW, K-WR, Y-CY, D-LW, Z-LZ, L-LZ, S-SZ); and Division of Pathology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China (X-JL).</aff>
      <author-notes>
        <corresp>Correspondence: Shu-sen Zheng, Professor of Medicine, Chief, Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health, Key Laboratory of Organ Transplantation, Division of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, Zhejiang Province, <country>China</country> (e-mail: <email>Shusen_zheng@163.com</email>).</corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>4</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>08</day>
        <month>4</month>
        <year>2016</year>
      </pub-date>
      <volume>95</volume>
      <issue>14</issue>
      <elocation-id>e3246</elocation-id>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>12</month>
          <year>2015</year>
        </date>
        <date date-type="rev-recd">
          <day>8</day>
          <month>3</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>8</day>
          <month>3</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2016 Wolters Kluwer Health, Inc. All rights reserved.</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0">
          <license-p>This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link></license-p>
        </license>
      </permissions>
      <self-uri xlink:type="simple" xlink:href="medi-95-e3246.pdf"/>
      <abstract>
        <title>Abstract</title>
        <p>Carcinosarcoma is a rare tumor consisting of epithelial and mesenchymal components, both of which are histologically malignant. It usually runs an aggressive clinical course, with higher metastatic potential than other kinds of carcinomas or sarcomas.</p>
        <p>Here, we present an extremely uncommon case of carcinosarcoma occurred in the lesser omental bursa in a 65-year-old Chinese man. Metastasis was observed 2 months after operation and disappeared completely after chemotherapy. Until now, 3 years after surgery, the patient is still alive without any signs or symptoms of recurrence.</p>
        <p>To our knowledge, this is the first case of carcinosarcoma originated from lesser omentum. Surgical resection and the ifosfamide-based combination chemotherapy may be effective to carcinosarcoma in the lesser omentum.</p>
      </abstract>
      <custom-meta-group>
        <custom-meta>
          <meta-name>OPEN-ACCESS</meta-name>
          <meta-value>TRUE</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Carcinosarcoma is defined as a rare neoplasm characterized by showing both carcinomatous and sarcomatous components. This rare tumor can locate in various organs, including gastrointestinal tract, liver, breast, especially the uterus, and female reproductive system.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> However, carcinosarcoma located in the lesser omentum has not been reported.</p>
      <p>The tumor usually runs an aggressive clinical course, with higher metastatic potential than other kinds of carcinomas or sarcomas, and the exact etiology of the tumor remains unknown yet.<sup><xref rid="R2" ref-type="bibr">2</xref></sup> It is reported that the risk factors of uterine carcinosarcoma include estrogen, nulliparity, tamoxifen, and pelvic radiation. However, the risk factors and etiology for the omentum carcinosarcoma remains a mystery because of its extremely low incidence. It is still not clearly understood of the histogenesis of carcinosarcoma, with 3 main hypotheses having been proposed: collision, combination, and conversion theories.<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R3" ref-type="bibr">3</xref></sup> Complete surgical resection of primary lesions with wide margins and suitable dissection of lymphnodes is usually a reasonable therapy. For uterine carcinosarcoma&#x2014;the most frequently occurring carcinosarcoma&#x2014;combination therapies including postoperative chemotherapy and radiation therapy are also indicated to be effective.<sup><xref rid="R4" ref-type="bibr">4</xref>&#x2013;<xref rid="R7" ref-type="bibr">7</xref></sup></p>
      <p>We presented an extremely uncommon case of carcinosarcoma originated from the lesser omentum. Solitary liver metastasis was detected 2 months after the operation and disappeared completely after adjunctive chemotherapy. At present, the patient is still alive with a good quality of life.</p>
    </sec>
    <sec>
      <title>CASE PRESENTATION</title>
      <p>A 65-year-old Chinese man was admitted to our hospital with a complaint of upper abdominal distention. There was no positive sign on physical examination. Tumor markers including carcino-embryonic antigen, carbohydrate atigen 19-9, alpha fetoprotein, and prostate specific antigen were normal. Abdominal enhanced computed tomography (CT) scan revealed a 5.4&#x200A;&#xD7;&#x200A;4.1&#x200A;cm<sup>2</sup> irregular soft tissue mass in the space between the liver and stomach (Figure <xref ref-type="fig" rid="F1">1</xref>A). In the arterial and venous phase, the mass enhanced gradually (Figure <xref ref-type="fig" rid="F1">1</xref>B and C). The magnetic resonance imaging (MRI) showed the mass had long T1 and T2 signal, and the diffusion-weighted imaging (DWI) revealed a high signal of the mass (Figure <xref ref-type="fig" rid="F1">1</xref>D&#x2013;F). Histopathological examination of endoscopic ultrasonography (EUS)-guided fine needle biopsy revealed malignant tumor cells (Figure <xref ref-type="fig" rid="F2">2</xref>). No evidence of distant metastasis was identified. Complete tumor resection and lymphadenectomy were performed. The protocol for the surgical resection was decided together by the patient and a multidisciplinary team from different departments including hepatobiliary surgery, radiology, and chemotherapy.</p>
      <fig id="F1" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>The presence of the carcinosarcoma in the CT and MRI before the peration. A, The CT showed a 5.4&#x200A;&#xD7;&#x200A;4.1&#x200A;cm<sup>2</sup> irregular soft tissue mass (white arrow) in the space between the liver and stomach. B, No obvious enhancement (white arrow) was showed in the enhanced abdominal CT scan. C, Slight enhancement (white arrow) was observed in the venous phase. D, The tumor (white arrow) was high signal in T1-weighted MRI. E, T2-weighted imaging revealed no enhancement of the tumor (white arrow). F, The tumor (white arrow) was located in the lesser omentum bursa. CT&#x200A;=&#x200A;computed tomography, MRI&#x200A;=&#x200A;magnetic resonance imaging.</p>
        </caption>
        <graphic xlink:href="medi-95-e3246-g001"/>
      </fig>
      <fig id="F2" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Histologic images of EUS (hematoxylin and eosin [H&amp;E] staining; 200&#xD7;).</p>
        </caption>
        <graphic xlink:href="medi-95-e3246-g002"/>
      </fig>
      <p>Grossly, the tumor was situated in the lesser omental bursa and measured 9.0&#x200A;&#xD7;&#x200A;5.0&#x200A;&#xD7;&#x200A;4.5&#x200A;cm<sup>3</sup> (Figure <xref ref-type="fig" rid="F3">3</xref>A). The inside of the tumor presented grayish-white color with necrosis (Figure <xref ref-type="fig" rid="F3">3</xref>B). Frozen section during the operation revealed that it was a malignant tumor with epithelioid and mesenchymal components.</p>
      <fig id="F3" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>The tumor and MRI after the surgery. A, The tumor measured about 9.0&#x200A;&#xD7;&#x200A;5.0&#x200A;&#xD7;&#x200A;4.5&#x200A;cm<sup>3</sup> with intact capsule. B, Inside the tumor, there was &#x201C;fish-meat&#x201D; like tissue with necrosis. C, Two months after the operation, the MR images showed a 1&#x200A;cm metastasis tumor (white arrow) in the left liver. D, After the second chemotherapy, the metastasis tumor disappeared from the left liver. MRI&#x200A;=&#x200A;magnetic resonance imaging.</p>
        </caption>
        <graphic xlink:href="medi-95-e3246-g003"/>
      </fig>
      <p>Histologically, the tumor showed biphasic differentiating. The first component was epithelium cells that arranged like cancer nests. Meanwhile, the second component revealed a sarcomatous growth pattern (Figure <xref ref-type="fig" rid="F4">4</xref>A). Immunohistological study indentified the tumor components by specific labeling techniques. Final diagnosis of carcinosarcoma was confirmed by hematoxylin and eosin (H&amp;E) staining and immunohistochemical analysis showing positive p63, pan-cytokeratin (CK), vimentin (VIM), CD99, and Bcl-2 (Figure <xref ref-type="fig" rid="F4">4</xref>B&#x2013;F). Postoperation diagnosis of the patient was primary carcinosarcoma of the lesser omentum without lymph node metastasis.</p>
      <fig id="F4" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>The pathology and histological study of the carcinosarcoma. A, H&amp;E staining (200&#xD7;) showed that the tumor tissue consisted of 2 well distinguished types of cells: carcinoma cells (black arrow) and sarcoma cells (white arrow). Immunohistochemistry (200&#xD7;) revealed that tumor cells were positive for p63 (B), CK (C), and VIM (D). Some tumor cells were positive for CD99 (E) and Bcl-2 (F). CK&#x200A;=&#x200A;pan-cytokeratin, H&amp;E&#x200A;=&#x200A;hematoxylin and eosin, VIM&#x200A;=&#x200A;vimentin.</p>
        </caption>
        <graphic xlink:href="medi-95-e3246-g004"/>
      </fig>
      <p>Two months after the operation, the MRI showed a 1&#x200A;cm mass in the left liver (Figure <xref ref-type="fig" rid="F3">3</xref>C) with enlarged lymph nodes in the retroperitoneal area; metastasis was considered. The patient refused a second operation and instead received chemotherapy. The chemotherapeutic protocol (epirubicin 28&#x200A;mg continuous intravenous infusion 24&#x200A;hours d1&#x2013;3 and ifosfemide 2&#x200A;g d1&#x2013;3, q3w) was scheduled as 1 time per month and lasted for 6 months till the end. After the chemotherapy regimen, the hepatic MRI showed that the left liver metastases disappeared completely (Figure <xref ref-type="fig" rid="F3">3</xref>D). Three months later, a hepatic MRI showed no recurrence in the patient's liver. The patient is still alive without any signs of recurrence during 3 years of follow-up.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Carcinosarcoma is a malignant tumor composed of mesenchymal and epithelial components.<sup><xref rid="R8" ref-type="bibr">8</xref></sup> This rare tumor locates in various organs, including gastrointestinal tract, liver, breast, especially the uterus, and female reproductive system.<sup><xref rid="R1" ref-type="bibr">1</xref></sup> As far as we know, our case is the unique documented case of carcinosarcoma apparently arising from omentum. It is still not clearly understood of the histogenesis of carcinosarcoma, with 3 main hypotheses having been proposed: collision, combination, and conversion theories.<sup><xref rid="R2" ref-type="bibr">2</xref>,<xref rid="R3" ref-type="bibr">3</xref></sup> The collision theory suggests that the epithelial cells and mesenchymal cells happen to occur and fuse at the common border and give the impression of a single mixed tumor.<sup><xref rid="R9" ref-type="bibr">9</xref></sup> The combination theory suggests that both the epithelial and mesenchymal components are derived from a common stem cell to form a single tumor.<sup><xref rid="R10" ref-type="bibr">10</xref></sup> The conversion theory is that epithelial cells transformed into malignant cells that give rise to a carcinoma. Also, cells in the carcinoma further undergo metaplastic transformation to give rise to a sarcoma.<sup><xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R12" ref-type="bibr">12</xref></sup> With the emergence of more and more molecular and genetic data, the conversion theory is being accepted by more scholars.<sup><xref rid="R13" ref-type="bibr">13</xref></sup></p>
      <p>The lesser omentum is a double layer of the peritoneum that connects the lesser curvature of the stomach and the first part of the duodenum to the porta hepatis. The common tumor of the omentum includes lipoma, liposarcoma, gastrointestinal stromal tumor, and mesothelioma.<sup><xref rid="R14" ref-type="bibr">14</xref></sup> However, primary carcinosarcomas originating from the omentum are very rare. Tumors of omentum can often occur insidiously without obvious signs or symptoms, until they grow large enough to compress adjacent organs. The symptoms present as abdominal discomfort, abdominal mass, and abdominal distention. The preoperation diagnosis of omental tumor mainly depends on ultrasound, CT, and MRI images. However, the final diagnosis relies on immunohistological analysis.<sup><xref rid="R15" ref-type="bibr">15</xref></sup></p>
      <p>Surgical resection is still the main treatment method of omental carcinosarcoma.<sup><xref rid="R8" ref-type="bibr">8</xref></sup> However, the effectiveness of surgery and chemotherapy has not been proved for the lack of enough omental carcinosarcoma cases. For uterine carcinosarcoma&#x2014;the most common carcinosarcomas&#x2014;R0 resection is usually a reasonable therapy. Combination therapies including postoperative chemotherapy and radiation therapy are also indicated to be effective to reduce the local recurrence of uterine carcinosarcoma, though it may not improve overall survival.<sup><xref rid="R16" ref-type="bibr">16</xref>&#x2013;<xref rid="R19" ref-type="bibr">19</xref></sup> Ifosfamide, cisplatin, and paclitaxel have been tried out to be effective against the uterine carcinosarcoma.<sup><xref rid="R10" ref-type="bibr">10</xref>,<xref rid="R20" ref-type="bibr">20</xref></sup> R0 resection was undertaken in our patient and metastasis was revealed in the left liver about 2 months after the operation. The patient accepted epirubicin and ifosfemide chemotherapy regimen and the metastasis disappeared after the chemotherapy. He felt well and had an uneventful recovery 3 years after the chemotherapy.</p>
    </sec>
    <sec sec-type="conclusion">
      <title>CONCLUSIONS</title>
      <p>The lesser omental carcinosarcoma is an extremely rare tumor with high malignancy and aggressive invasiveness that has never been reported. The tumor can metastasize to the adjacent organs. Surgical resection associated with a combination of chemotherapy with ifosfamide and epirubicin may be effective for the tumor.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgment</title>
      <p>We thank Gui-Fei Yu for assisting in preparation of this manuscript.</p>
    </ack>
    <fn-group>
      <fn fn-type="abbr">
        <p>Abbreviations: CK = pan-cytokeratin, CT = computed tomography, DWI = diffusion-weighted imaging, EUS = endoscopic ultrasonography, H&amp;E = hematoxylin and eosin, MRI = magnetic resonance imaging, VIM = vimentin.</p>
      </fn>
      <fn fn-type="equal">
        <p>BW and K-WR contributed equally.</p>
      </fn>
      <fn fn-type="con">
        <p>Author contributions: BW and K-WR conduct the study and collected the data; Y-CY and D-LW processed the data and wrote the manuscript; X-JL provided pathological pictures; Z-LZ and L-LZ proofread and approved the manuscript; S-SZ performed critical review and proofread the manuscript.</p>
      </fn>
      <fn fn-type="COI-statement">
        <p>The authors have no funding and conflicts of interest to disclose.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="R1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weidner</surname><given-names>N</given-names></name><name><surname>Zekan</surname><given-names>P</given-names></name></person-group>
<article-title>Carcinosarcoma of the colon. Report of a unique case with light and immunohistochemical studies</article-title>. <source><italic>Cancer</italic></source>
<year>1986</year>; <volume>58</volume>:<fpage>1126</fpage>&#x2013;<lpage>1130</lpage>.<pub-id pub-id-type="pmid">2425931</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abeln</surname><given-names>EC</given-names></name><name><surname>Smit</surname><given-names>VT</given-names></name><name><surname>Wessels</surname><given-names>JW</given-names></name><etal/></person-group>
<article-title>Molecular genetic evidence for the conversion hypothesis of the origin of malignant mixed mullerian tumours</article-title>. <source><italic>J Pathol</italic></source>
<year>1997</year>; <volume>183</volume>:<fpage>424</fpage>&#x2013;<lpage>431</lpage>.<pub-id pub-id-type="pmid">9496259</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wada</surname><given-names>H</given-names></name><name><surname>Enomoto</surname><given-names>T</given-names></name><name><surname>Fujita</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors</article-title>. <source><italic>Cancer Res</italic></source>
<year>1997</year>; <volume>57</volume>:<fpage>5379</fpage>&#x2013;<lpage>5385</lpage>.<pub-id pub-id-type="pmid">9393763</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sutton</surname><given-names>G</given-names></name><name><surname>Brunetto</surname><given-names>VL</given-names></name><name><surname>Kilgore</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: a Gynecologic Oncology Group Study</article-title>. <source><italic>Gynecol Oncol</italic></source>
<year>2000</year>; <volume>79</volume>:<fpage>147</fpage>&#x2013;<lpage>153</lpage>.<pub-id pub-id-type="pmid">11063636</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curtin</surname><given-names>JP</given-names></name><name><surname>Blessing</surname><given-names>JA</given-names></name><name><surname>Soper</surname><given-names>JT</given-names></name><etal/></person-group>
<article-title>Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group study</article-title>. <source><italic>Gynecol Oncol</italic></source>
<year>2001</year>; <volume>83</volume>:<fpage>268</fpage>&#x2013;<lpage>270</lpage>.<pub-id pub-id-type="pmid">11606082</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toyoshima</surname><given-names>M</given-names></name><name><surname>Akahira</surname><given-names>J</given-names></name><name><surname>Matsunaga</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Clinical experience with combination paclitaxel and carboplatin therapy for advanced or recurrent carcinosarcoma of the uterus</article-title>. <source><italic>Gynecol Oncol</italic></source>
<year>2004</year>; <volume>94</volume>:<fpage>774</fpage>&#x2013;<lpage>778</lpage>.<pub-id pub-id-type="pmid">15350372</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clayton Smith</surname><given-names>D</given-names></name><name><surname>Kenneth Macdonald</surname><given-names>O</given-names></name><name><surname>Gaffney</surname><given-names>DK</given-names></name></person-group>
<article-title>The impact of adjuvant radiation therapy on survival in women with uterine carcinosarcoma</article-title>. <source><italic>Radiother Oncol</italic></source>
<year>2008</year>; <volume>88</volume>:<fpage>227</fpage>&#x2013;<lpage>232</lpage>.<pub-id pub-id-type="pmid">18160157</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piura</surname><given-names>B</given-names></name><name><surname>Rabinovich</surname><given-names>A</given-names></name><name><surname>Apel-Sarid</surname><given-names>L</given-names></name><etal/></person-group>
<article-title>Carcinosarcoma of the fallopian tube with metastasis of its epithelial component to the ovary, appendix and omentum</article-title>. <source><italic>J Obstet Gynaecol</italic></source>
<year>2009</year>; <volume>29</volume>:<fpage>566</fpage>&#x2013;<lpage>567</lpage>.<pub-id pub-id-type="pmid">19697224</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>KY</given-names></name><name><surname>Khoo</surname><given-names>US</given-names></name><name><surname>Cheung</surname><given-names>A</given-names></name></person-group>
<article-title>Collision of endometrioid carcinoma and stromal sarcoma of the uterus: a report of two cases</article-title>. <source><italic>Int J Gynecol Pathol</italic></source>
<year>1999</year>; <volume>18</volume>:<fpage>77</fpage>&#x2013;<lpage>81</lpage>.<pub-id pub-id-type="pmid">9891246</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>R</given-names></name></person-group>
<article-title>Review literature on uterine carcinosarcoma</article-title>. <source><italic>J Cancer Res Ther</italic></source>
<year>2014</year>; <volume>10</volume>:<fpage>461</fpage>&#x2013;<lpage>468</lpage>.<pub-id pub-id-type="pmid">25313723</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCluggage</surname><given-names>WG</given-names></name></person-group>
<article-title>Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas</article-title>. <source><italic>Int J Gynecol Cancer</italic></source>
<year>2002</year>; <volume>12</volume>:<fpage>687</fpage>&#x2013;<lpage>690</lpage>.<pub-id pub-id-type="pmid">12445244</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Nashar</surname><given-names>SA</given-names></name><name><surname>Mariani</surname><given-names>A</given-names></name></person-group>
<article-title>Uterine carcinosarcoma</article-title>. <source><italic>Clin Obstet Gynecol</italic></source>
<year>2011</year>; <volume>54</volume>:<fpage>292</fpage>&#x2013;<lpage>304</lpage>.<pub-id pub-id-type="pmid">21508698</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kernochan</surname><given-names>LE</given-names></name><name><surname>Garcia</surname><given-names>RL</given-names></name></person-group>
<article-title>Carcinosarcomas (malignant mixed Mullerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics</article-title>. <source><italic>J Natl Comprehensive Cancer Netw</italic></source>
<year>2009</year>; <volume>7</volume>:<fpage>550</fpage>&#x2013;<lpage>556</lpage>.<comment>quiz 557</comment>.</mixed-citation>
      </ref>
      <ref id="R14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sompayrac</surname><given-names>SW</given-names></name><name><surname>Mindelzun</surname><given-names>RE</given-names></name><name><surname>Silverman</surname><given-names>PM</given-names></name><etal/></person-group>
<article-title>The greater omentum</article-title>. <source><italic>Am J Roentgenol</italic></source>
<year>1997</year>; <volume>168</volume>:<fpage>683</fpage>&#x2013;<lpage>687</lpage>.<pub-id pub-id-type="pmid">9057515</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nam</surname><given-names>SH</given-names></name><name><surname>Park</surname><given-names>JA</given-names></name><name><surname>Kim</surname><given-names>YM</given-names></name></person-group>
<article-title>Primary malignant rhabdoid tumor of greater omentum in 10-year-old girl</article-title>. <source><italic>Ann Surg Treatment Res</italic></source>
<year>2014</year>; <volume>86</volume>:<fpage>50</fpage>&#x2013;<lpage>53</lpage>.</mixed-citation>
      </ref>
      <ref id="R16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callister</surname><given-names>M</given-names></name><name><surname>Ramondetta</surname><given-names>LM</given-names></name><name><surname>Jhingran</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Malignant mixed Mullerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome</article-title>. <source><italic>Int J Radiat Oncol Biol Phys</italic></source>
<year>2004</year>; <volume>58</volume>:<fpage>786</fpage>&#x2013;<lpage>796</lpage>.<pub-id pub-id-type="pmid">14967435</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holtz</surname><given-names>F</given-names></name><name><surname>Fox</surname><given-names>JE</given-names></name><name><surname>Abell</surname><given-names>MR</given-names></name></person-group>
<article-title>Carcinosarcoma of the urinary bladder</article-title>. <source><italic>Cancer</italic></source>
<year>1972</year>; <volume>29</volume>:<fpage>294</fpage>&#x2013;<lpage>304</lpage>.<pub-id pub-id-type="pmid">5013534</pub-id></mixed-citation>
      </ref>
      <ref id="R18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galaal</surname><given-names>K</given-names></name><name><surname>van der Heijden</surname><given-names>E</given-names></name><name><surname>Godfrey</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma</article-title>. <source><italic>Cochrane Database Syst Rev</italic></source>
<year>2013</year>; <volume>2</volume>:<fpage>Cd006812</fpage>.<pub-id pub-id-type="pmid">23450572</pub-id></mixed-citation>
      </ref>
      <ref id="R19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shylasree</surname><given-names>TS</given-names></name><name><surname>Bryant</surname><given-names>A</given-names></name><name><surname>Athavale</surname><given-names>R</given-names></name></person-group>
<article-title>Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma</article-title>. <source><italic>Cochrane Database Syst Rev</italic></source>
<year>2013</year>; <volume>2</volume>:<fpage>Cd006246</fpage>.<pub-id pub-id-type="pmid">23450567</pub-id></mixed-citation>
      </ref>
      <ref id="R20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Homesley</surname><given-names>HD</given-names></name><name><surname>Filiaci</surname><given-names>V</given-names></name><name><surname>Markman</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study</article-title>. <source><italic>J Clin Oncol</italic></source>
<year>2007</year>; <volume>25</volume>:<fpage>526</fpage>&#x2013;<lpage>531</lpage>.<pub-id pub-id-type="pmid">17290061</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
